Synthesis of pharmaceuticals with light

The classical biaryl synthesis route contains catalysts based on heavy metals (above) whereas the new reaction uses a metal-free sulfonamide linker that fragments into gases when exposed to UV-light. Florian Kloss / HKI

The team of Christian Hertweck observed in a synthesis study that certain ring-shaped molecules, co-called bis-arylsulfonamides, convert into a blue fluorescent substance when exposed to UV light. Analyses revealed that the product of this reaction is a biaryl.

The coupling is highly selective for the geometrical configuration, resulting in a high yield of a nearly pure reaction product, despite a multitude of theoretical combination possibilities. The sulfonamide linker in combination with UV light fulfils the same function as heavy metal catalysts used up to now. Contamination of the product by traces of toxic metals can thus be avoided. In order to demonstrate the transferability of this new reaction to a larger scale, the chemists have designed a suitable reactor, termed photosplicer.

First investigations show a wide range of applications for this new photosplicing technology. The researchers were able to synthesize a range of pharmaceutically important biaryls without the use of heavy metals. Among them were active ingredients of blockbuster drugs with more than 1 billion USD annual turnover, such as antihypertensive agents, anti-inflammatories, cytostatic agents, pain relievers or active ingredients for neurodegenerative diseases.

Many pharmaceuticals but also agrochemicals or the displays of electronic devices contain biaryls. Two ring-shaped molecular building blocks are coupled to each other via a simple chemical bond. The precise spatial structure is thereby significant for the efficacy or functionality of the compounds. The two ring-shaped building blocks therefore have to be coupled in the correct position and configuration.

For decades heavy metal catalysts have been used for this coupling, mostly palladium-containing compounds. However, these conventional methods, for which the Nobel Prize in Chemistry was awarded in 2010, have disadvantages: the metal catalysts are expensive and traces of the mostly toxic compounds remain in the reaction products.

The annual turnover of pharmaceutical biaryl products is estimated to be above 30 billion USD. The antihypertensives from the active ingredient group of the sartanes account for several billion USD. Even small improvements in the manufacturing processes therefore offer an immense potential for savings or profit.

The leader of the research team, Christian Hertweck, Head of Department at the Leibniz HKI and professor at the Friedrich Schiller University Jena, comments on the novel reaction: ‘We have not worked specifically on the development of a new synthesis method. It was rather a discovery along the way, which our team has noticed attentively and soon we recognized its enormous potential. Such developments cannot be planned on the drawing board and realized in fixed work plans. A free mind, an inspiring team and a collaborative research environment ultimately lead to success – and lucky coincidence also plays a role.’

Florian Kloss, who has discovered the reaction during his doctoral research and who now is head of the transfer group Anti-infectives, says: ‘As coincidental as the first observation of the reaction was, the parallels to metal-catalyzed reactions seemed obvious to us. Nevertheless we were surprised when our subsequent analyses revealed such wide range of potential applications for this new technology. We are confident that we can synthesize a variety of other substances with this method that we do not have an eye on yet. The production of larger quantities of valuable materials is now more of a technical development work.’

Florian Kloss, +49 3641 1356, florian.kloss@leibniz-hki.de
Christian Hertweck, +49 3641 5321101, christian.hertweck@leibniz-hki.de

Kloss F, Neuwirth T, Haensch V, Hertweck (2018) Metal-free synthesis of pharmaceutically important biaryls by photosplicing. Angew Chem Int Ed doi: 10.1002/anie.201805961.

https://www.leibniz-hki.de/en/press-releases.html

Media Contact

Dr. Michael Ramm idw - Informationsdienst Wissenschaft

Alle Nachrichten aus der Kategorie: Life Sciences

Articles and reports from the Life Sciences area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Zurück zur Startseite

Kommentare (0)

Schreib Kommentar

Neueste Beiträge

Argonne targets lithium-rich materials as key to more sustainable cost-effective batteries

Next-generation batteries using lithium-rich materials could be more sustainable and cost-effective, according to a team of researchers with the U.S. Department of Energy’s (DOE) Argonne National Laboratory. The pivotal discovery,…

Why disordered light-harvesting systems produce ordered outcomes

Scientists typically prefer to work with ordered systems. However, a diverse team of physicists and biophysicists from the University of Groningen found that individual light-harvesting nanotubes with disordered molecular structures…

RadarGlass – from vehicle headlight to radar transceiver

As a result of modern Advanced Driver Assistance Systems, the use of radar technology has become indispensable for the automotive sector. With the installation of a large and growing number…

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close